Mario Eisenberger

Johns Hopkins University, Johns Hopkins Medical Institutes, United States of America

Mario Eisenberger

Academic positions:
- R. Dale Hughes Professor of Oncology and Urology

Any industry positions (last five years):
None declared

Research interests:
Dr. Eisenberger's research focuses on clinical trials in patients with urological cancers. His major research efforts are in the area of prostate cancer. Over the past several years Dr. Eisenberger has established his expertise in the design and conduct of clinical trials in patients with various stages of prostate cancer. He has organized an effective infrastructure to conduct pilot and large scale trials ranging from phase I/II/ and III studies with promising compounds. Recent accomplishments include a large, multi-institutional,multinational study that demonstrated, for the first time a significant survival advantage with chemotherapy in patients with hormone-refractory disease. This resulted in the FDA approval of a widely used cytotoxic drug, docetaxel, for prostate cancer. He currently chairs several other trials attempting to build on the activity of this compound. In the area of early prostate cancer, in collaboration with the department of urology, he has participated in investigations that defined the outcome of patients with biochemically relapsed disease after radical prostatectomy. This represents an ongoing investigation of the Johns Hopkins large data base on these patients which has generated critical clinical information used in the management of these patients and for the design of clinical trials. Dr. Eisenberger is the chairman of a large multinational adjuvant chemo/hormonal therapy for patients with high risk prostate cancer after radical prostatectomy.


Any other information:
Dr Eisenberger has a number of professional responsibilities:
- Member ECOG - (GU Committee)
- Member, Prostate cancer foundation clinical consortium
- Member, Bladder Cancer Committee, NCCN
- Member, Cancer Related Fatigue , NCCN
- National Prostate Cancer Education Council
- American Association of Cancer Research (AACR)
- Past Member, International Task Force, American Society of Clinical Oncology

Any competing interests declared are displayed with individual evaluations.

Section Head: Oncology > Genitourinary Cancers (since 16 November 2005)

Mario Eisenberger is a Section Head for Genitourinary Cancers, part of the ONCOLOGY Faculty. The role of a Section Head is to work with their Co-Section Head(s) to divide the Section (sub-specialty area) into its component areas of research, nominate leaders in those areas as Faculty Members, and offer ongoing oversight of the content within their Section. They are not asked to evaluate articles, although we do, of course, welcome them.

Links

http://urology.jhu.edu/